The following article requires a subscription:



(Format: HTML, PDF)

Why are some less solidly supported health care innovations widely adopted while others with apparently stronger scientific support remain underused? Drawing on four case studies, the authors argue that the way in which the distribution of benefits and risks map onto the interests, values, and power distribution of the adopting system is critical to understanding how innovations diffuse.

Copyright (C) 2002 by Aspen Publishers, Inc.